Whether peptide therapy is appropriate depends on the specific treatment being considered, your medical history, symptoms, current medications, laboratory findings, and individual health goals.

Because peptide therapies vary significantly in their mechanisms, clinical evidence, potential risks, and regulatory status, treatment should be individualized. At RenewFX, patients are evaluated before peptide-related therapy is recommended, with appropriate physician oversight and monitoring when treatment is initiated.

Human growth hormone (HGH) therapy uses recombinant growth hormone to directly supplement growth hormone in patients with medically appropriate indications. Certain peptide therapies work differently by influencing pathways involved in the body’s own growth hormone signaling.

These treatments differ in their mechanisms, clinical uses, potential benefits, risks, and regulatory status. They should not be considered interchangeable.

At RenewFX, growth hormone–related treatment options are evaluated individually based on medical history, symptoms, laboratory findings, and whether a particular therapy is medically appropriate.

Laboratory testing depends on the specific therapy being considered, your medical history, and treatment goals. Evaluation may include hormone markers such as IGF-1, as well as thyroid, metabolic, blood glucose, liver, kidney, cardiovascular, and other relevant health markers when clinically appropriate.

Baseline testing can help establish your health status before treatment, while follow-up testing allows the physician to evaluate response and monitor relevant markers over time.

At RenewFX, laboratory monitoring is individualized according to the therapy being used and the patient’s overall health and response to treatment.

FDA approval depends on the specific peptide. Some peptide-based medications are FDA-approved for particular medical conditions, while other peptides promoted for wellness, recovery, body composition, or longevity may not be currently approved for those uses. The availability of individual peptide therapies can change over time.

At RenewFX, treatment options are evaluated based on current regulations, available clinical evidence, individual patient needs, and whether a particular therapy can be appropriately prescribed and obtained through a properly licensed pharmacy.

Certain growth hormone–related peptides and medications can influence pathways involved in the body’s natural production and release of growth hormone. Increased growth hormone signaling may subsequently increase insulin-like growth factor 1 (IGF-1), which mediates many of growth hormone’s effects in the body.

The response varies depending on the specific therapy, dose, age, baseline hormone status, overall health, and individual physiology.

When growth hormone–related therapy is medically appropriate, RenewFX may use IGF-1 and other relevant laboratory markers to evaluate baseline status and monitor treatment response.

RenewFX Health & Wellness provides physician-guided evaluation for peptide-related therapies for appropriate patients in Houston and through telemedicine across Texas.

Treatment begins with a review of medical history, symptoms, current medications, treatment goals, and relevant laboratory findings. Because peptide therapies vary in their clinical evidence, regulatory status, and availability, treatment options are considered individually rather than using a standardized peptide protocol.

When a therapy is medically appropriate and legally available, RenewFX provides individualized treatment planning, appropriate laboratory monitoring, and ongoing medical oversight.